Physician

Philip Penrose, M.D.

According to 2025 Medicare claims, Philip Penrose, M.D. (NPI: 1245288547) practices ophthalmology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is EYEMD ON CASS A PROFESSIONAL CORPORATION (NPI: 1205095742; TIN: 262519565) and primary practice location at 93940-2948.

Penrose's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,945 traditional Medicare patients, billed 8,231 HCPCS/CPT codes, and received $827,706 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,682 prescription claims across 536 beneficiaries totaling $249,229 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 28 records totaling $810. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $399,944 to $827,706. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$414K$828K2015 Medicare payment: $399,944 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $386,178 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $431,012 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $436,574 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $449,356 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $414,998 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $578,873 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $790,090 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $789,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $827,706 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3743,556$399,944
20161,3863,647$386,178
20171,4614,090$431,012
20181,4934,295$436,574
20191,5644,663$449,356
20201,4254,280$414,998
20211,5175,238$578,873
20221,6536,802$790,090
20231,8026,998$789,115
20241,9458,231$827,706

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$177K$353K2015 Drug cost: $248,923 (USD; Tot_Drug_Cst)2016 Drug cost: $278,308 (USD; Tot_Drug_Cst)2017 Drug cost: $307,460 (USD; Tot_Drug_Cst)2018 Drug cost: $353,274 (USD; Tot_Drug_Cst)2019 Drug cost: $345,014 (USD; Tot_Drug_Cst)2020 Drug cost: $315,897 (USD; Tot_Drug_Cst)2021 Drug cost: $307,186 (USD; Tot_Drug_Cst)2022 Drug cost: $332,559 (USD; Tot_Drug_Cst)2023 Drug cost: $294,732 (USD; Tot_Drug_Cst)2024 Drug cost: $249,229 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153711,664$248,923
20164151,780$278,308
20174412,007$307,460
20184982,154$353,274
20194551,866$345,014
20204351,829$315,897
20214241,646$307,186
20224941,721$332,559
20235001,591$294,732
20245361,682$249,229

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,2581,271$90
92012Established patient problem focused exam of visual system366613$70
92134Imaging of retina811879$32
92133Imaging of optic nerve391398$28
95919Measurement of pupil with healthcare professional interpretation and report743744$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast232,010$43,190
RestasisCyclosporine342,100$42,554
Bromfenac SodiumBromfenac Sodium1024,464$25,372
ProlensaBromfenac Sodium572,487$19,343
CyclosporineCyclosporine312,220$17,335

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$810ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Penrose, M.D.?

Tedicare shows public-source Medicare data for Philip Penrose, M.D. (NPI 1245288547), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Penrose, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Penrose, M.D.?

Philip Penrose, M.D. is linked to EYEMD ON CASS A PROFESSIONAL CORPORATION (billing NPI 1205095742) in the available physician profile data.

Does Philip Penrose, M.D. have Open Payments data?

Philip Penrose, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.